Lang F P, Pollock B H, Riley W J, Maclaren N K, Barrett D J
Department of Pathology and Laboratory Medicine, University of Florida College of Medicine, Gainesville.
J Autoimmun. 1993 Feb;6(1):107-19. doi: 10.1006/jaut.1993.1009.
We previously reported a significant increase in percentages of peripheral blood gamma delta+ T cells in islet cell antibody (ICA) positive relatives of patients with insulin-dependent diabetes (IDD). In the present study, we further characterized this T cell abnormality in a larger group of ICA+ subjects and report that (1) Percentages of gamma delta+ T lymphocytes were significantly increased only in subjects with high ICA titers (> or = 20 JDF units) (P = 0.005) and resulted from an increase in absolute numbers of gamma delta+ T lymphocytes. (2) In these subjects, the increase in gamma delta+ T lymphocytes was associated with an increase in the V gamma 9 V delta 2 subpopulation (r = 0.99). (3) In these same subjects, high percentages of gamma delta+ T lymphocytes were associated with normal beta cell function while low percentages were associated with diminished insulin response. Using 65 microU/ml as the threshold of abnormal intravenous glucose tolerance test (IVGTT) response, percentages of gamma delta+ T lymphocytes could significantly predict IVGTT status in these subjects (P < 0.01). A longitudinal follow-up further suggested that the development of an abnormal IVGTT response and progression to diabetes was associated with a decrease in percentages of gamma delta+ T lymphocytes while patients whose gamma delta+ T cell percentages remained high retained normal beta cell function. Our data therefore suggest that gamma delta+ T lymphocytes and more specifically V gamma 9 V delta 2 T cells are implicated in the autoimmune process leading to diabetes and may have a regulatory role. The monitoring of their percentages in the blood of patients at risk for diabetes may be useful as an additional predictor of diabetes development.
我们之前报道过,胰岛素依赖型糖尿病(IDD)患者的胰岛细胞抗体(ICA)阳性亲属外周血γδ+ T细胞百分比显著增加。在本研究中,我们在更大的ICA+受试者群体中进一步对这种T细胞异常进行了特征分析,并报告如下:(1)仅在ICA滴度高(≥20 JDF单位)的受试者中,γδ+ T淋巴细胞百分比显著增加(P = 0.005),且这是由于γδ+ T淋巴细胞绝对数量增加所致。(2)在这些受试者中,γδ+ T淋巴细胞的增加与Vγ9Vδ2亚群的增加相关(r = 0.99)。(3)在这些相同的受试者中,γδ+ T淋巴细胞高百分比与正常β细胞功能相关,而低百分比与胰岛素反应减弱相关。以65 μU/ml作为静脉葡萄糖耐量试验(IVGTT)异常反应的阈值,γδ+ T淋巴细胞百分比可显著预测这些受试者的IVGTT状态(P < 0.01)。一项纵向随访进一步表明,IVGTT异常反应的出现和糖尿病进展与γδ+ T淋巴细胞百分比降低相关,而γδ+ T细胞百分比保持高值的患者保留正常β细胞功能。因此,我们的数据表明,γδ+ T淋巴细胞,更具体地说是Vγ9Vδ2 T细胞,参与了导致糖尿病的自身免疫过程,可能具有调节作用。监测糖尿病高危患者血液中它们的百分比,可能作为糖尿病发生的额外预测指标。